Clinical Trials Logo

Clinical Trial Summary

Performing intravenous (IV) cannulation to pediatric patients might be much harder than adult ones according to their anxiety levels. However, managing adult patients during intravenous cannulation is also challenging if he or she had a noxious memory about the situation or has a low pain threshold. Therefore, it is essential to relieve the pain of an IV needle or an IV cannula insertion in the pediatric patient population. Lidocaine Hcl spray (Xylocaine 10% Oral ) will be utilized to the research group, and Serum Physiologic (Serum Fizyolojik %0,9 10 ml ampule, Biofarma İlaç San. ve Tic A.Ş., İstanbul, Turkey) will be utilized to the control group of the study. Both medications will be administrated by spraying the formula three times to an adhesive bandage and placing it to the skin that IV cannulation will be performed. After waiting for a minimum of 5 to a maximum of 15 minutes ( waiting time is closely associated with the patient's anxiety level), IV cannulation will be performed from the same area by an experienced pediatric nurse. The investigator hypothesizes that utilizing the spray form of the Lidocaine Hcl formula to the skin with an adhesive bandage before IV cannulation might lower the pain of the manipulation in pediatric patients, which might cause lower anxiety levels with stable vital signs.


Clinical Trial Description

The G-Power 3.0.10. Computed required sample size (alpha:0.05, effect size:0.3 and power 0.8) related to t-test of the difference between two dependent means(matched pairs) according to the 5% change of before and after heartbeat outcome parameters with Standard derivations of ( -/+12 to +/-15). The total sample size of ninety participants is evaluated to be enough for the study. However, fifty participants are planned to be enrolled in each group (a total of 100 participants) to compensate for possible losses in this prospective, randomized clinical study. Six parameters will be evaluated, and three scales will be performed in each group. The six parameters are Heart Rate-1, Spo2-1, Body Temperature-1, Heart Rate-2, Spo2-2, Body Temperature-2. The three scales are 11 point Verbal Numeric Rating Scale-1, 11 point Verbal Numeric Rating Scale-2, and Visual Analog Scale. Those parameters will be measured non-invasively, without causing any pain.

The randomization is planned to be done with the sealed envelope modeling. One of the envelopes is planned to be chosen by each participant after the written consent form approval from the child and his/her parents. The envelopes have either a "C" letter or "L" letter inside representing C as {Group C: "The Control Group"}, representing L as {Group L: "The Lidocaine Group"} will be opened by the principal investigator. The bottle 1(Serum Physiologic inside) or bottle 2( Lidocaine inside) will be given to the ward nurse according to the letters in the envelope. The ward nurse will be blinded according to the ingredients in the bottles. The outcome parameters and the scales will be recorded by the nurse in the investigation. The nurse in the investigation will be blinded about the groups, the envelopes and the ingredients performed to the participants.

The study is planned to last in 4 months (16 weeks) time. However, in the middle of the study( 25 participants undertaken within each group), post-doc tests are planned to be done. If the power of the study according to the post-Hoc tests are more than 80%, the study will be stopped. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04246255
Study type Interventional
Source Yeditepe University
Contact
Status Completed
Phase Phase 4
Start date February 3, 2020
Completion date August 24, 2020

See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Completed NCT03262857 - Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block Phase 2
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Not yet recruiting NCT02535273 - The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia Phase 4
Not yet recruiting NCT05902780 - Can Caudal Dexmedetomidine Provide Effective Analgesia? N/A
Completed NCT04885777 - Topical Lidocaine Anesthesia for Nasopharyngeal Sampling N/A
Recruiting NCT04086394 - PECS Block in Partial Mastectomy for Postoperative Pain Control N/A
Recruiting NCT06129162 - Pain Perception Comparison of Computerized vs Conventional Injection Methods N/A
Completed NCT02922504 - Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia N/A
Completed NCT00539084 - A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia N/A
Completed NCT03176446 - Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment N/A
Completed NCT04947267 - To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor Phase 2
Completed NCT02825225 - A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes N/A
Completed NCT01360749 - Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal Phase 2
Completed NCT00889642 - Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers Phase 2
Not yet recruiting NCT06395987 - Result Of Use Of Wide Awake Local Anaesthesia In Fixation Of Ankle Fractures
Active, not recruiting NCT05473819 - Effectiveness of Sodium Bicarbonate Buffered Anaesthetic Solution on Pain During Injection N/A
Completed NCT04653974 - Pain Perception of Needle-free System N/A
Completed NCT02884596 - Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Completed NCT02440347 - Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block Phase 4